The embolization coils market size is expected to grow from US$ 1,877.12 million in 2024 to US$ 3,685.07 million by 2031; it is projected to register a CAGR of 10.2% during 2025-2031. The rising prevalence of vascular disorders and aneurysms, burgeoning demand for minimally invasive procedures, and an aging population are noteworthy factors contributing to the expansion of the embolization coils market size. Additionally, the development of next-generation embolic materials is projected to bring new embolization coils market trends in the near future.

Next-generation embolic materials improve the precision, biocompatibility, and long-term effectiveness of minimally invasive procedures. Traditional platinum coils have been transformed into advanced hybrids, which combine hydrogels, bioactive polymers, and shape-memory alloys to overcome problems such as recanalization and incomplete occlusion. In fact, the EMBOLD Fibered Detachable Coil is an excellent case of the coil being a fibered design that facilitates thrombus formation and thus reduces blood flow in the peripheral vessels. Besides, this coil maximizes packing density in complex anatomies, thus minimizing the risks of migration during deployment.

Drug-eluting coils are one more invention in this field, where bioactive agents like paclitaxel or sirolimus are incorporated to avoid restenosis. Studies with these coils in peripheral artery embolization have demonstrated a 25% decrease in the rate of revascularization of target lesions, compared to the rate for bare platinum counterparts. Similar to that, shape-memory alloys and fibered platinum coils raise packing density; fibered designs achieve significantly higher immediate occlusion rates by promoting thrombus formation. During 2023, hydrogel-coated coils became available; thus, clotting efficiency was raised by 30% and biocompatibility, which leads to fewer inflammatory responses in vivo.

In oncology, drug-eluting coils provide the local delivery of chemotherapy; thus, progression-free survival in hepatocellular carcinoma cases is extended by 40% compared to the conventional methods. These technologies not only decrease the time of the procedure but also facilitate the shift to outpatient settings, which is in line with patient-centric care. With the increasing investments in research and development, the combination of shape-memory hydrogels is expected to result in coils that are fully adaptive and thus, by 2031, will have a great impact on occlusion durability and the widening of application in urology and cardiology fields, thereby emerging as a significant trend in the embolization coils market.

End User-Based Insights

Based on end user, the embolization coils market is segmented into hospitals, ambulatory centers, and others. The hospitals segment held the largest embolization coils market share in 2024. Hospitals are the main places where coil deployments take place worldwide, as they are the central facilities for diagnosing and treating vascular disorders like cerebral aneurysms, arteriovenous malformations (AVMs), and embolizations related to oncology. For example, in neurology, interventional radiologists in hospital catheterization labs employ detachable platinum coils to close off brain aneurysms, thus ruptures that may lead to strokes are avoided-a procedure demonstrated by the treatment of more than 2 million cases of abdominal aortic aneurysm annually in the U.S., which is a fact reported by the vascular societies. This portion's growth is due to a number of factors that are closely related to each other. The increased prevalence of lifestyle-induced diseases such as hypertension and diabetes has led to an increase in cardiovascular risks, which in turn is the main reason for the demand for minimally invasive interventions. On the one hand, hospitals' state-of-the-art imaging systems (for example fluoroscopy) and multidisciplinary teams make it possible for coils to be positioned very precisely, thus, the danger is greatly diminished as compared to open surgery. On the other hand, the large-scale implementation of endovascular techniques-giving the possibility of short recovery time and lessening the risks-has significantly increased the number of procedures performed. To mention a few, the technological advances like the introduction of bioactive coils, which not only close the vessels but also facilitate thrombosis, are a great source of improvement in terms of efficacy. In cancer, the use of transarterial chemoembolization with the help of coils to cut off the blood supply to the tumors, for example, in the case of hepatocellular carcinoma, is definitely a great showcase of how hospitals are the centers for innovative care. Hence, due to increased healthcare spending in emerging markets and the aging global population, the expansion is even greater, and hospitals are thereby positioned as a must for scalable embolization services that cater to patients with high-acuity needs, thereby fueling the embolization coils market growth.

The World Health Organization and Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the embolization coils market report.